For prevention of diabetic retinopathy (DR) incidence or progression, the American Academy of Ophthalmology Preferred Practice Pattern (AAO PPP) and the American Diabetes Association Standards of Care ...
For sura-vec in wet AMD, top line data from pivotal studies ATMOSPHERE and ASCENT are anticipated in Q4. First patient dosing in NAVIGATE for diabetic retinopathy is planned next quarter, expected to ...
Diabetic retinopathy develops through complex microvascular damage driven by chronic hyperglycemia, yet traditional risk factors such as disease duration or glycemic control explain only part of ...
Hydroxychloroquine (HCQ) is used to treat many rheumatologic conditions, but retinopathy and vision loss can occur with long-term dosing. For HCQ-related retinopathy, solid estimates of prevalence, ...
3d
Can Diabetic Macular Edema (DME) Be Prevented? What to Know About Early Detection and Risk Reduction
DME is a diabetes complication that threatens your the clarity of your vision. But managing blood sugar, blood pressure, and ...
In studies published so far, GLP-1 receptor agonists appear to be beneficial for the treatment of glaucoma, according to a review published in Cureus.“GLP-1 RAs exert both protective and adverse ...
Tirzepatide use is linked to lower risks of incident and progressive diabetic retinopathy compared with lifestyle intervention alone.
Artificial intelligence (AI) has become an indispensable tool in Estonian hospitals, aiding both stroke and radiation therapy treatment while saving doctors hours of valuable time. At the same time, ...
A newly identified protein may hold the key to preventing diabetic blindness. Researchers discovered that LRG1 triggers the ...
Why do diabetic wounds refuse to heal? A new scientific review highlights how disruptions in the timing and behavior of ...
The nutrient metabolism of patients with type 2 diabetes mellitus (T2DM) is closely linked to diabetes-related complications. Nutrient metabolism ...
Susvimo is an FDA-approved eye implant for diabetic macular edema that may reduce monthly injections to just two treatments a year while maintaining vision outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results